oasis 1 oral semaglutide 50 mg obesity nejm 2023 Orforglipron, an Small-Molecule GLP-1 Receptor Agonist for Treatment Oral Semaglutide 25 mg and

Current Evidence Emerging research suggests that GLP-1 receptor agonists may influence alcohol consumption patterns, though there is no official indication for these medications in treating alcohol use disorder , and the evidence base remains preliminary

They require proper medical evaluation

Use pH-neutral washes and avoid scented products while treating symptoms

Smaller meals and snacks are often easier to tolerate and easier to repeat consistently

Unique trans-kingdom Microbiome structural and functional signatures predict cognitive decline in older adults

Receiving a diagnosis early on can help keep MASLD from doing a lot of damage to your liver